We are a global leader in the development and delivery of enterprise software for the implementation of genomics in clinical applications. The breadth of our bioinformatics products, services, and support capabilities can help any healthcare institution establish a personalized medicine capability.
Our continually curated Knowledge Base has a long and trusted reputation as the most advanced database of biological and clinical findings in the life science industry. It has been used by researchers, clinicians, and pharmaceutical companies for more than 16 years and has been cited in more than 20,000 scientific publications.
Production testing is the implementation of validated tests, variant calling pipelines, and clinical interpretation workflows under a certified production environment to build reports for requesting physicians.
QCI™ Interpret addresses this by facilitating evidence-based clinical decision making through best-in-class interpretation of variant data.
Advanced testing of patient cases unresolved with routine panels often requires analyzing whole exomes or genomes to determine causative variants. Our Hereditary Disease Solution is a flexible enterprise platform that enables clinical labs to solve more patient cases with superior accuracy and without bioinformatics expertise.
Our capabilities and investments in developing clinical bioinformatics solutions will become increasingly relevant as the research and clinical community scales from panels to exomes and ultimately to whole genomes for personalized medicine. This trend will continue to demand the use of our highly sophisticated computational solutions with the perpetually curated QIAGEN Knowledge Base to predict phenotypic impacts of genomic variation.
Dr. Michael Hadjisavas, VP of Clinical Genomics Program, QIAGEN Bioinformatics.
QIAGEN’s Biomedical Genomics Workbench and Ingenuity Variant Analysis are highly specialized software solutions for assay development. Our solution allows clinical laboratories to rapidly evaluate and iterate variant calling and interpretation pipelines during analytical development of a particular assay.Find out more about clinical development
The QIAGEN Knowledge Base enables highly efficient determination of biomarkers that are relevant for specific patient populations. By using our Knowledge Base, clinical laboratories can mitigate risk and rapidly expand their test menu roadmap for new disease indications.Discover more about content development
© QIAGEN 2019. All rights reserved - Trademarks & Disclaimers